Ujjaini Dasgupta

12PUBLICATIONS
40CO-AUTHORS
Transport properties and non-equilibrium processesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 01, 2026
Ceramide transfer protein regulates G-protein-coupled phospholipase signalling in photoreceptors.

|Nov 20, 2025
Localized Hydrogel-Mediated Docetaxel-Carboplatin Combination Chemotherapy Targets Ganglioside Metabolism to Mitigate Tumor Progression.

Mohammad Nafees Ansari, Jasleen Kaur, Ali Khan

|Sep 11, 2025
The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms.

Mohammad Nafees Ansari, Somesh K Jha, Ali Khan

|Feb 19, 2025
Docetaxel-conjugated bile acid-derived nanomicelles can inhibit tumour progression with reduced toxicity.

Devashish Mehta, Chhavi Dua, Ruchira Chakraborty

|Dec 19, 2024
Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies.

Devashish Mehta, Kajal Rajput, Dolly Jain

|May 13, 2024
Engineered nanomicelles targeting proliferation and angiogenesis inhibit tumour progression by impairing the synthesis of ceramide-1-phosphate.

Poonam Yadav, Kajal Rana, Ruchira Chakraborty

Pageof 2

Frequent Collaborators

8 joint publications

Avinash Bajaj

6 joint publications

Devashish Mehta

4 joint publications

Kajal Rana

4 joint publications

Animesh Kar